Agenus Inc.

NasdaqCM:AGEN Stok Raporu

Piyasa değeri: US$100.3m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Agenus Yönetim

Yönetim kriter kontrolleri 2/4

Agenus' CEO'su Garo Armen, Jan1994 tarihinde atandı, in görev süresi 30.75 yıldır. in toplam yıllık tazminatı $ 5.86M olup, şirket hissesi ve opsiyonları dahil olmak üzere 12.1% maaş ve 87.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.7% ine doğrudan sahiptir ve bu hisseler $ 832.25K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.8 yıl ve 4 yıldır.

Anahtar bilgiler

Garo Armen

İcra Kurulu Başkanı

US$5.9m

Toplam tazminat

CEO maaş yüzdesi12.1%
CEO görev süresi30.8yrs
CEO sahipliği0.7%
Yönetim ortalama görev süresi2.8yrs
Yönetim Kurulu ortalama görev süresi4yrs

Son yönetim güncellemeleri

Recent updates

Agenus: Novel Drugs That Just Are Not Novel

Jul 24

There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise

May 21
There's No Escaping Agenus Inc.'s (NASDAQ:AGEN) Muted Revenues Despite A 102% Share Price Rise

Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

May 09
Analysts Have Lowered Expectations For Agenus Inc. (NASDAQ:AGEN) After Its Latest Results

Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet

Mar 29
Benign Growth For Agenus Inc. (NASDAQ:AGEN) Underpins Stock's 25% Plummet

Agenus: 2024 May Finally Be The Year For A Major Turnaround

Jan 18

Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet

Dec 22
Improved Revenues Required Before Agenus Inc. (NASDAQ:AGEN) Shares Find Their Feet

News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts

Nov 09
News Flash: Analysts Just Made A Huge Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Forecasts

A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)

Oct 04
A Look At The Fair Value Of Agenus Inc. (NASDAQ:AGEN)

Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts

May 10
Industry Analysts Just Made A Notable Upgrade To Their Agenus Inc. (NASDAQ:AGEN) Revenue Forecasts

VBI Vaccines, Agenus to examine VBI-1901 + balstilimab combo for glioblastoma

Oct 12

Agenus New Trials Set It Up For The Long Haul

Sep 27

Agenus: It's Always Tomorrow

Sep 16

Agenus GAAP EPS of -$0.17, revenue of $20.93M

Aug 09

Agenus: Successfully Pulled Itself Away From Disaster

Jul 04

Agenus: Not Quite Enough

Apr 19

Auditors Have Doubts About Agenus (NASDAQ:AGEN)

Mar 06
Auditors Have Doubts About Agenus (NASDAQ:AGEN)

Agenus: Making Another Effort With The FDA

Jan 25

Agenus Inc.'s Imminent 1181/Bal Data Release And MiNK IPO Should Lead To Enormous Valuation Gains

Aug 25

Agenus Multiple Value-Adding Events Ahead

Aug 18

Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts

Aug 11
Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts

CEO Tazminat Analizi

Garo Armen'un ücretlendirmesi Agenus'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$224m

Mar 31 2024n/an/a

-US$240m

Dec 31 2023US$6mUS$710k

-US$246m

Sep 30 2023n/an/a

-US$271m

Jun 30 2023n/an/a

-US$263m

Mar 31 2023n/an/a

-US$240m

Dec 31 2022US$6mUS$689k

-US$220m

Sep 30 2022n/an/a

-US$215m

Jun 30 2022n/an/a

US$18m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$10mUS$655k

-US$24m

Sep 30 2021n/an/a

US$4m

Jun 30 2021n/an/a

-US$226m

Mar 31 2021n/an/a

-US$190m

Dec 31 2020US$6mUS$677k

-US$181m

Sep 30 2020n/an/a

-US$174m

Jun 30 2020n/an/a

-US$168m

Mar 31 2020n/an/a

-US$171m

Dec 31 2019US$10mUS$634k

-US$108m

Sep 30 2019n/an/a

-US$126m

Jun 30 2019n/an/a

-US$113m

Mar 31 2019n/an/a

-US$87m

Dec 31 2018US$3mUS$610k

-US$160m

Sep 30 2018n/an/a

-US$147m

Jun 30 2018n/an/a

-US$151m

Mar 31 2018n/an/a

-US$158m

Dec 31 2017US$4mUS$593k

-US$121m

Tazminat ve Piyasa: Garo 'nin toplam tazminatı ($USD 5.86M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 677.23K ).

Tazminat ve Kazançlar: Garo şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Garo Armen (71 yo)

30.8yrs

Görev süresi

US$5,856,319

Tazminat

Dr. Garo H. Armen, Ph.D. founded Agenus Inc. in 1994 and has been Chief Executive Officer since 1994. He serves as an Executive Chairman at MiNK Therapeutics, Inc. Dr. Armen serves as an Executive Chairman...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Garo Armen
Founder30.8yrsUS$5.86m0.70%
$ 706.2k
Christine Klaskin
VP of Finance18yrsUS$712.75k0.036%
$ 35.8k
Steven O'Day
Chief Medical Officer3.8yrsUS$1.44m0.063%
$ 63.3k
Craig Winter
Chief Information Officer2.8yrsVeri yokVeri yok
Zack Armen
Head of Investor Relationsno dataVeri yokVeri yok
Tracy Clemente
Chief People Officer2.8yrsVeri yokVeri yok
Alfred Dadson
Chief Manufacturing Officerno dataVeri yokVeri yok
Eric Humes
Chief Quality Officer2.8yrsVeri yokVeri yok
Todd Yancey
Member of Advisory Board & Chief Strategic Advisorless than a yearVeri yokVeri yok
Robin Taylor
Chief Commercial Officer1.3yrsVeri yokVeri yok
Nils Eckardt
Chief Medical Affairs Officerless than a yearVeri yokVeri yok
Jennifer Buell
Director and President & CEO of MiNK Therapeutics2.8yrsUS$7.42m0.063%
$ 63.6k

2.8yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim: AGEN 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.8 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Garo Armen
Founder25.8yrsUS$5.86m0.70%
$ 706.2k
Todd Yancey
Member of Advisory Board & Chief Strategic Advisor1.8yrsVeri yokVeri yok
Jennifer Buell
Director and President & CEO of MiNK Therapeuticsless than a yearUS$7.42m0.063%
$ 63.6k
Robert Stein
Member of Advisory Board1.8yrsUS$1.04mVeri yok
Ulf Wiinberg
Independent Director8.4yrsUS$366.39k0.029%
$ 28.8k
Timothy Wright
Independent Lead Director17.8yrsUS$385.50k0.013%
$ 12.9k
Larry Norton
Member of Advisory Board1.8yrsVeri yokVeri yok
Brian Corvese
Independent Director17.6yrsUS$888.14k0.021%
$ 21.4k
Susan Hirsch
Independent Director4yrsUS$242.00k0.028%
$ 27.6k

4.0yrs

Ortalama Görev Süresi

68.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: AGEN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4 yıldır).